Synthetic approaches to 1,2,4-triazolo[5,1-c][1,2,4]triazin-7-ones as basic heterocyclic structures of the antiviral drug Riamilovir ("Triazavirin®") active against SARS-CoV-2 (COVID-19).
| Autor: | Artem'ev, Grigory A., Rusinov, Vladimir L., Kopchuk, Dmitry S., Savchuk, Maria I., Santra, Sougata, Ulomsky, Eugeny N., Zyryanov, Grigory V., Majee, Adinath, Du, Weijie, Charushin, Valery N., Chupakhin, Оleg N. |
|---|---|
| Zdroj: | Organic & Biomolecular Chemistry; 3/7/2022, Vol. 20 Issue 9, p1828-1837, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|